Literature DB >> 18822435

Longitudinal changes in myelin water fraction in two MS patients with active disease.

I M Vavasour1, C Laule, D K B Li, J Oger, G R W Moore, A Traboulsee, A L MacKay.   

Abstract

Multiple sclerosis (MS) is characterised by focal areas that undergo cycles of demyelination and remyelination. Although conventional magnetic resonance imaging is very effective in localising areas of damage, these techniques are not pathology specific. A newer technique, T(2) relaxation, can separate water from brain into three compartments: (1) a long T(2) component (>2 s) arising from CSF, (2) an intermediate T(2) component (~80 ms) attributed to intra- and extra-cellular water and (3) a short T(2) component (~20 ms) assigned to water trapped in between the myelin bilayers (termed myelin water). Histological evidence shows that myelin water is a specific marker of myelination. The goal of this work was to follow changes in total water content (WC) and myelin water fraction (MWF) in evolving MS lesions over one year. Multi-echo T(2) relaxation data was collected and used to measure water content and myelin water fraction from three new MS lesions in two patients. WC increased in the three large (>1 cm(3)) lesions at lesion appearance and remained elevated in the central core. Two lesions showed low MWF in the core suggesting demyelination upon first appearance. At later time points, one lesion showed a decrease in volume of low MWF, reflecting remyelination whereas the volume of low MWF in the other lesion core remained constant. This work provides evidence that MWF and WC can monitor demyelination and remyelination in MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822435     DOI: 10.1016/j.jns.2008.08.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

Review 1.  Inferring brain tissue composition and microstructure via MR relaxometry.

Authors:  Mark D Does
Journal:  Neuroimage       Date:  2018-01-02       Impact factor: 6.556

Review 2.  MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.

Authors:  Ulrike W Kaunzner; Susan A Gauthier
Journal:  Ther Adv Neurol Disord       Date:  2017-05-12       Impact factor: 6.570

Review 3.  Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.

Authors:  Thomas Tourdias; Vincent Dousset
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

Review 4.  Quantitative relaxometry of the brain.

Authors:  Sean C L Deoni
Journal:  Top Magn Reson Imaging       Date:  2010-04

Review 5.  Achievements and obstacles of remyelinating therapies in multiple sclerosis.

Authors:  Martin Stangel; Tanja Kuhlmann; Paul M Matthews; Trevor J Kilpatrick
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

6.  Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.

Authors:  Sneha Pandya; Ulrike W Kaunzner; Sandra M Hurtado Rúa; Nancy Nealon; Jai Perumal; Timothy Vartanian; Thanh D Nguyen; Susan A Gauthier
Journal:  J Neuroimaging       Date:  2020-06-24       Impact factor: 2.486

Review 7.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.

Authors:  Frederik Barkhof; Peter A Calabresi; David H Miller; Stephen C Reingold
Journal:  Nat Rev Neurol       Date:  2009-05       Impact factor: 42.937

8.  Feasibility of imaging myelin lesions in multiple sclerosis.

Authors:  Maria I Zavodszky; John F Graf; Cristina A Tan Hehir
Journal:  Int J Biomed Imaging       Date:  2011-08-15

9.  High-resolution quantitative MRI of multiple sclerosis spinal cord lesions.

Authors:  Amy R McDowell; Natalia Petrova; Daniele Carassiti; Marc E Miquel; David L Thomas; Gareth J Barker; Klaus Schmierer; Tobias C Wood
Journal:  Magn Reson Med       Date:  2022-01-11       Impact factor: 3.737

10.  A Comparison of Quantitative R1 and Cortical Thickness in Identifying Age, Lifespan Dynamics, and Disease States of the Human Cortex.

Authors:  A Erramuzpe; R Schurr; J D Yeatman; I H Gotlib; M D Sacchet; K E Travis; H M Feldman; A A Mezer
Journal:  Cereb Cortex       Date:  2021-01-05       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.